Dr Reddy Labs launches 2-DG oral anti-COVID drug commercially

In the initial weeks, the company will make the drug available in hospitals across metros and tier I cities, and subsequently expand coverage to the rest of India. The price for the drug has been pegged at Rs. 990 for private procurements while for government supply, a subsidized rate will be offered.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3hftffM
via IFTTT